Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Advanced Micro

(AMD) - Get Report

rated new Hold at Jefferies. $7.50 price target. Company has attractive growth prospects, but a vacuum in the CEO position.

Ametek

(AME) - Get Report

rated new Neutral at UBS. $47 price target. Valuation near full at present prices.

AutoNation

(AN) - Get Report

downgraded at Wells from Market Perform to Underperform. New vehicle sales have been lower across the industry in May and June.

Avery Dennison

(AVY) - Get Report

downgraded at Baird from Outperform to Neutral. $39 price target. Disappointing 2Q pre-announcement and related lowering of FY11 expectations.

Check Point Software

(CHKP) - Get Report

upgraded at BofA/Merrill from Neutral to Buy. Estimates also boosted. $71 price target.

Carlisle Companies

(CSL) - Get Report

upgraded at FBR from Underperform to Market Perform, FBR Capital Markets said. $45 price target. Commercial construction market is improving and raw materials costs have pulled back.

Quest Diagnostics

(DGX) - Get Report

downgraded at Jefferies from Buy to Hold. $64 price target. Healthcare services could remain under pressure, as unemployment figures remain high.

Edwards Lifesciences

(EW) - Get Report

rated new Neutral at Credit Suisse. Valuation call, based on a $99 price target.

Fusion-io

(FIO)

rated new Outperform at Credit Suisse. $40 price target. Company is leveraged to continued demand from datacenters.

Fusion-io

(FIO)

rated new Neutral at JP Morgan. Valuation call, based on a $35 price target.

Hershey Foods

(HSY) - Get Report

rated new Neutral at Ticonderoga Securities. Valuation call, as the stock is pricing in market share gains.

IDEX Corp.

(IEX) - Get Report

upgraded at UBS from Neutral to Buy. $52 price target. Pullback offers attractive entry point.

Intel

(INTC) - Get Report

rated new Hold at Jefferies. $25 price target. Company is leveraged to decelerating PC demand.

Kellogg

(K) - Get Report

rated new Neutral at Ticonderoga. Company is in the midst of an earnings transition.

Nuvasive

(NUVA) - Get Report

upgraded at Baird from Neutral to Outperform. $42 price target. Spine market has likely bottomed out.

Scotts Miracle-Gro

(SMG) - Get Report

downgraded at BMO to Market Perform. $50 price target. MAT28 is facing increased scrutiny.

Thoratec

(THOR) - Get Report

rated new Outperform at Credit Suisse. $43 price target. Company can continue to grow its market share across the globe.

Texas Instruments

(TXN) - Get Report

rated new Buy at Jefferies. $38 price target. NSM purchase should allow the company to grow within the analog market.

VCA Antech

(WOOF)

upgraded at BofA/Merrill from Underperform to Buy. $28 price target. Recent acquisitions should help augment growth.

End of report.

This article was written by a staff member of TheStreet.